针灸治疗帕金森病的有效性与安全性:随机对照试验的系统评价与Meta分析
该系统评价纳入42项随机对照试验共2625例帕金森病患者,评估针灸治疗的有效性与安全性。Meta分析显示针灸联合常规药物在UPDRS总分及各分项和Webster量表上优于单用常规药物,但针刺与安慰针刺在UPDRS总分上无显著差异,且纳入研究方法学质量低,无严重不良事件报告。
要点
- 针灸联合常规药物可能改善帕金森病UPDRS总分及各分项和Webster量表评分。
- 电针联合常规药物在UPDRS总分、I、II、IV上优于单用常规药物,但在UPDRS III、Webster和紧张评估量表上无显著优势。
- 针刺与安慰针刺在UPDRS总分上无显著差异,纳入研究方法学质量低,结论需谨慎。
核心结论
- 针灸可能是帕金森病患者安全且有用的辅助治疗,但因纳入研究方法学缺陷,尚缺乏确凿证据。
研究设计与样本
- 系统评价与Meta分析,检索英文、中文和韩文电子数据库至2016年6月,纳入随机对照试验,共42项研究涉及2625例参与者。
- 采用Cochrane偏倚风险工具评估方法学质量,使用RevMan 5.3进行Meta分析。
主要发现
- 针灸联合常规药物在UPDRS总分、UPDRS I、UPDRS II、UPDRS III和Webster量表上较单用常规药物有显著改善。
- 电针联合常规药物在UPDRS总分、UPDRS I、UPDRS II和UPDRS IV上显著优于单用常规药物。
- 头电针、针刺联合常规药物在UPDRS总分上显著优于单用常规药物。
- 电针联合常规药物在UPDRS III、Webster量表和紧张评估量表上与单用常规药物无显著差异。
- 针刺与安慰针刺在UPDRS总分上无显著差异,未报告严重不良事件。
临床怎么用
- 针灸可作为帕金森病的辅助治疗与常规药物联合使用,但需向患者说明证据质量较低。
- 电针联合常规药物可能对UPDRS总分及部分分项有益,但对UPDRS III和Webster量表未见显著优势。
局限性
- 纳入的随机对照试验方法学质量总体较低。
- 针刺与安慰针刺在UPDRS总分上无显著差异,提示安慰效应可能影响结果。
- 因方法学缺陷,尚缺乏确凿证据,需更多严格设计的安慰剂对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to examine the effectiveness and safety of acupuncture in the treatment of Parkinson's disease (PD). METHODS: English, Chinese, and Korean electronic databases were searched up to June 2016. Randomized controlled trials (RCTs) were eligible. The methodological quality was assessed using Cochrane's risk of bias tool. Meta-analysis was performed using RevMan 5.3. RESULTS: In total, 42 studies involving 2625 participants were systematically reviewed. Participants treated using combined acupuncture and conventional medication (CM) showed significant improvements in total Unified PD Rating Scale (UPDRS), UPDRS I, UPDRS II, UPDRS III, and the Webster scale compared to those treated using CM alone. The combination of electroacupuncture and CM was significantly superior to CM alone in total UPDRS, UPDRS I, UPDRS II, and UPDRS IV. Similarly, the combination of scalp electroacupuncture, acupuncture, and CM was significantly more effective than CM alone in total UPDRS. However, our meta-analysis showed that the combination of electroacupuncture and CM was not significantly more effective than CM alone in UPDRS III, the Webster, and the Tension Assessment Scale. The results also failed to show that acupuncture was significantly more effective than placebo acupuncture in total UPDRS. Overall, the methodological quality of the RCTs was low. No serious adverse events were reported. CONCLUSIONS: We found that acupuncture might be a safe and useful adjunctive treatment for patients with PD. However, because of methodological flaws in the included studies, conclusive evidence is still lacking. More rigorous and well-designed placebo-controlled trials should be conducted.
引用
- Noh H, Kwon S, Cho SY, et al. Effectiveness and safety of acupuncture in the treatment of Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2017. PMID: 28917379. doi:10.1016/j.ctim.2017.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。